30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Bellerophon Therapeutics Inc (BLPH)

Track

Stock chart
Ticker: BLPH Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Puissance Capital Management LP
1 sale — total 111,776 USD
Sale 13 Oct 2023
Value US$3,772,579.57 | Price 263.26 | Shares 1,134
Proposed sale 7 Jun 2023
Value US$502,265.92 | Price 165.63 | Shares 92,783
Sale 7 Jun 2023
Value US$4,420,056.45 | Price 124.28 | Shares 46,695
Sale 18 May 2023
Value US$94,550.00 | Price 10.00 | Shares 9,455
Sale 18 May 2023
Value US$5,297,600.00 | Price 9.46 | Shares 560,000
Proposed sale 18 May 2023
Value US$5,297,600.00 | Price 9.46 | Shares 560,000
Sale 18 Mar 2021
Value US$2,192,000.00 | Price 5.48 | Shares 400,000
Buy 10 Sep 2020
Value US$40,708.00 | Price 10.18 | Shares 4,000
Buy 8 Jun 2020
Value US$33,454.20 | Price 12.87 | Shares 2,600
Buy 5 Jun 2020
Value US$63,441.86 | Price 12.72 | Shares 4,986
Buy 25 Nov 2019
Value US$2,773.62 | Price 0.39 | Shares 7,193
Buy 22 Nov 2019
Value US$393.54 | Price 0.37 | Shares 1,050
Buy 21 Nov 2019
Value US$74.00 | Price 0.37 | Shares 200
Sale 28 Oct 2019
Value US$146,091.49 | Price 0.44 | Shares 333,010
Sale 28 Oct 2019
Value US$146,091.49 | Price 0.44 | Shares 333,010
Sale 25 Oct 2019
Value US$25,511.37 | Price 0.45 | Shares 56,242
Sale 25 Oct 2019
Value US$25,511.37 | Price 0.45 | Shares 56,242
Sale 24 Oct 2019
Value US$353,354.39 | Price 0.50 | Shares 704,595
Sale 24 Oct 2019
Value US$353,354.39 | Price 0.50 | Shares 704,595
Buy 12 Jun 2019
Value US$31,905.00 | Price 0.64 | Shares 50,000
Buy 22 May 2019
Value US$16,533.00 | Price 0.60 | Shares 27,500
Buy 21 May 2019
Value US$2,975.00 | Price 0.60 | Shares 5,000
Buy 21 May 2019
Value US$12,198.00 | Price 0.61 | Shares 20,000
Buy 21 May 2019
Value US$26,370.50 | Price 0.61 | Shares 43,280
Buy 25 Jan 2019
Value US$315,000.00 | Price 0.70 | Shares 450,000
Buy 25 Jan 2019
Value US$500,000.20 | Price 0.70 | Shares 714,286
Buy 25 Jan 2019
Value US$400,000.30 | Price 0.70 | Shares 571,429
Buy 23 Jan 2019
Value US$99,999.90 | Price 0.70 | Shares 142,857
Buy 23 Jan 2019
Value US$99,999.90 | Price 0.70 | Shares 142,857
Buy 17 Sep 2018
Value US$70,944.00 | Price 1.18 | Shares 60,000
Buy 17 Sep 2018
Value US$70,944.00 | Price 1.18 | Shares 60,000
Buy 14 Sep 2018
Value US$92,250.00 | Price 1.23 | Shares 75,000
Buy 14 Sep 2018
Value US$92,250.00 | Price 1.23 | Shares 75,000
Buy 13 Sep 2018
Value US$89,160.00 | Price 1.19 | Shares 75,000
Buy 13 Sep 2018
Value US$89,160.00 | Price 1.19 | Shares 75,000
Buy 12 Sep 2018
Value US$85,912.50 | Price 1.15 | Shares 75,000
Buy 12 Sep 2018
Value US$85,912.50 | Price 1.15 | Shares 75,000
Buy 11 Sep 2018
Value US$228,840.00 | Price 1.14 | Shares 200,000
Buy 11 Sep 2018
Value US$228,840.00 | Price 1.14 | Shares 200,000
Buy 10 Sep 2018
Value US$243,640.00 | Price 1.22 | Shares 200,000
Buy 10 Sep 2018
Value US$243,640.00 | Price 1.22 | Shares 200,000
Buy 7 Sep 2018
Value US$53,742.00 | Price 0.90 | Shares 60,000
Buy 7 Sep 2018
Value US$53,742.00 | Price 0.90 | Shares 60,000
Buy 6 Sep 2018
Value US$42,095.00 | Price 0.84 | Shares 50,000
Buy 6 Sep 2018
Value US$42,095.00 | Price 0.84 | Shares 50,000
Buy 5 Sep 2018
Value US$42,325.00 | Price 0.85 | Shares 50,000
Buy 5 Sep 2018
Value US$42,325.00 | Price 0.85 | Shares 50,000
Buy 16 Aug 2018
Value US$43,108.97 | Price 0.65 | Shares 66,393
Buy 16 Aug 2018
Value US$43,108.97 | Price 0.65 | Shares 66,393
Buy 15 Aug 2018
Value US$175,902.40 | Price 0.65 | Shares 272,000
Buy 15 Aug 2018
Value US$175,902.40 | Price 0.65 | Shares 272,000
Buy 14 Aug 2018
Value US$123,867.68 | Price 0.65 | Shares 190,977
Buy 14 Aug 2018
Value US$123,867.68 | Price 0.65 | Shares 190,977
Buy 29 Sep 2017
Value US$0.00 | Price 0.00 | Shares 456,432
Buy 29 Sep 2017
Value US$0.00 | Price 0.00 | Shares 248,962
Buy 29 Sep 2017
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 9 Dec 2016
Value US$11,200.00 | Price 0.56 | Shares 20,000
Buy 29 Nov 2016
Value US$0.00 | Price 0.00 | Shares 142,857
Buy 29 Nov 2016
Value US$0.00 | Price 0.00 | Shares 714,285
Buy 29 Nov 2016
Value US$0.00 | Price 0.00 | Shares 285,715
Buy 17 May 2016
Value US$6,841.50 | Price 1.37 | Shares 5,000
Buy 16 Dec 2015
Value US$35,335.68 | Price 2.76 | Shares 12,800
Buy 15 Dec 2015
Value US$20,400.00 | Price 2.72 | Shares 7,500
Buy 19 Aug 2015
Value US$27,377.00 | Price 5.48 | Shares 5,000
Buy 20 May 2015
Value US$48,323.07 | Price 8.69 | Shares 5,560
Buy 20 May 2015
Value US$5,980.80 | Price 8.40 | Shares 712
Buy 19 Feb 2015
Value US$12,841,992.00 | Price 12.00 | Shares 1,070,166
Buy 19 Feb 2015
Value US$12,841,992.00 | Price 12.00 | Shares 1,070,166
Buy 19 Feb 2015
Value US$2,551,992.00 | Price 12.00 | Shares 212,666
Buy 19 Feb 2015
Value US$4,306,992.00 | Price 12.00 | Shares 358,916
Buy 19 Feb 2015
Value US$144,000.00 | Price 12.00 | Shares 12,000
Buy 19 Feb 2015
Value US$300,000.00 | Price 12.00 | Shares 25,000
Buy 19 Feb 2015
Value US$18,000.00 | Price 12.00 | Shares 1,500
Buy 19 Feb 2015
Value US$12,841,992.00 | Price 12.00 | Shares 1,070,166
Buy 19 Feb 2015
Value US$2,551,992.00 | Price 12.00 | Shares 212,666
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-16 2023-10-13 S Sale
2.6
Puissance Capital Management LP
Large shareholder
1,134 -3.4%
263.26
US$3,772,580 		1,134 -3.4% 263.26 US$3,772,580
2023-06-07 2023-06-07 PrS Proposed sale
3.7
Puissance Life Science Opportunities Fund VI

10% Stockholder

Large shareholder
92,783
165.63
US$502,266 		92,783 165.63 US$502,266
2023-06-07 2023-06-07 S Sale
3.7
Puissance Life Science Opportunities Fund VI
Large shareholder
46,695 -36.9%
124.28
US$4,420,056 		46,695 -36.9% 124.28 US$4,420,056
2023-05-22 2023-05-18 S Sale
3.4
Kim Bobae

VP Reg. Affairs & Quality

Officer
9,455 -84.6%
10.00
US$94,550 		9,455 -84.6% 10.00 US$94,550
2023-05-19 2023-05-18 S Sale
3.7
Puissance Life Science Opportunities Fund VI
Large shareholder
560,000 -31.6%
9.46
US$5,297,600 		560,000 -31.6% 9.46 US$5,297,600
2023-05-18 2023-05-18 PrS Proposed sale
3.7
Puissance Life Science Opportunities Fund VI

10% Stockholder

Large shareholder
560,000
9.46
US$5,297,600 		560,000 9.46 US$5,297,600
2021-03-22 2021-03-18 S Sale
New Mountain Investments II, LLC
Large shareholder
400,000 -39.6%
5.48
US$2,192,000 		400,000 -39.6% 5.48 US$2,192,000
2020-09-14 2020-09-10 B Purchase
0.7
FARES Wassim

Chief Medical Officer

Officer
4,000 +inf%
10.18
US$40,708 		4,000 +inf% 10.18 US$40,708
2020-06-09 2020-06-08 B Purchase
2.5
Wang Theodore T
Non-Executive Director Large shareholder
2,600 +4.5%
12.87
US$33,454 		2,600 +4.5% 12.87 US$33,454
2020-06-09 2020-06-05 B Purchase
2.5
Wang Theodore T
Non-Executive Director Large shareholder
4,986 +9.3%
12.72
US$63,442 		4,986 +9.3% 12.72 US$63,442
2019-11-25 2019-11-25 B Purchase
2.5
Wang Theodore T
Non-Executive Director Large shareholder
7,193 +1.2%
0.39
US$2,774 		7,193 +1.2% 0.39 US$2,774
2019-11-25 2019-11-22 B Purchase
2.5
Wang Theodore T
Non-Executive Director Large shareholder
1,050 +0.2%
0.37
US$394 		1,050 +0.2% 0.37 US$394
2019-11-25 2019-11-21 B Purchase
2.5
Wang Theodore T
Non-Executive Director Large shareholder
200 +0.0%
0.37
US$74 		200 +0.0% 0.37 US$74
2019-10-28 2019-10-28 S Sale
1.8
VENROCK ASSOCIATES IV L P
Large shareholder
333,010 -4.9%
0.44
US$146,091 		333,010 -4.9% 0.44 US$146,091
2019-10-28 2019-10-28 S Sale
1.8
VENROCK ASSOCIATES IV L P
Large shareholder
333,010 -4.9%
0.44
US$146,091 		333,010 -4.9% 0.44 US$146,091
2019-10-28 2019-10-25 S Sale
1.8
VENROCK ASSOCIATES IV L P
Large shareholder
56,242 -0.8%
0.45
US$25,511 		56,242 -0.8% 0.45 US$25,511
2019-10-28 2019-10-25 S Sale
1.8
VENROCK ASSOCIATES IV L P
Large shareholder
56,242 -0.8%
0.45
US$25,511 		56,242 -0.8% 0.45 US$25,511
2019-10-28 2019-10-24 S Sale
1.8
VENROCK ASSOCIATES IV L P
Large shareholder
704,595 -9.4%
0.50
US$353,354 		704,595 -9.4% 0.50 US$353,354
2019-10-28 2019-10-24 S Sale
1.8
VENROCK ASSOCIATES IV L P
Large shareholder
704,595 -9.4%
0.50
US$353,354 		704,595 -9.4% 0.50 US$353,354
2019-06-14 2019-06-12 B Purchase
2.5
Wang Theodore T
Large shareholder
50,000 +9.4%
0.64
US$31,905 		50,000 +9.4% 0.64 US$31,905
2019-05-24 2019-05-22 B Purchase
2.5
Wang Theodore T
Large shareholder
27,500 +5.4%
0.60
US$16,533 		27,500 +5.4% 0.60 US$16,533
2019-05-22 2019-05-21 B Purchase
2.4
Tenenbaum Fabian

Chief Executive Officer

Executive Director
5,000 +1.0%
0.60
US$2,975 		5,000 +1.0% 0.60 US$2,975
2019-05-22 2019-05-21 B Purchase
1.5
Peacock Jonathan M
20,000 +1.1%
0.61
US$12,198 		20,000 +1.1% 0.61 US$12,198
2019-05-22 2019-05-21 B Purchase
2.5
Wang Theodore T
Large shareholder
43,280 +9.3%
0.61
US$26,371 		43,280 +9.3% 0.61 US$26,371
2019-01-25 2019-01-25 B Purchase
2.5
Wang Theodore T
Non-Executive Director Large shareholder
450,000 +3284.9%
0.70
US$315,000 		450,000 +3284.9% 0.70 US$315,000
2019-01-25 2019-01-25 B Purchase
1.5
Peacock Jonathan M
Non-Executive Director
714,286 +62.6%
0.70
US$500,000 		714,286 +62.6% 0.70 US$500,000
2019-01-25 2019-01-25 B Purchase
0.8
Amin Naseem
Non-Executive Director
571,429 +45.8%
0.70
US$400,000 		571,429 +45.8% 0.70 US$400,000
2019-03-14 2019-01-23 B Purchase
1.8
VENROCK ASSOCIATES IV L P
Large shareholder
142,857 +1.9%
0.70
US$100,000 		142,857 +1.9% 0.70 US$100,000
2019-03-14 2019-01-23 B Purchase
1.8
VENROCK ASSOCIATES IV L P
Large shareholder
142,857 +1.9%
0.70
US$100,000 		142,857 +1.9% 0.70 US$100,000
2018-09-17 2018-09-17 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
60,000 +0.8%
1.18
US$70,944 		60,000 +0.8% 1.18 US$70,944
2018-09-17 2018-09-17 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
60,000 +0.8%
1.18
US$70,944 		60,000 +0.8% 1.18 US$70,944
2018-09-17 2018-09-14 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
75,000 +1.0%
1.23
US$92,250 		75,000 +1.0% 1.23 US$92,250
2018-09-17 2018-09-14 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
75,000 +1.0%
1.23
US$92,250 		75,000 +1.0% 1.23 US$92,250
2018-09-17 2018-09-13 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
75,000 +1.0%
1.19
US$89,160 		75,000 +1.0% 1.19 US$89,160
2018-09-17 2018-09-13 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
75,000 +1.0%
1.19
US$89,160 		75,000 +1.0% 1.19 US$89,160
2018-09-12 2018-09-12 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
75,000 +1.1%
1.15
US$85,912 		75,000 +1.1% 1.15 US$85,912
2018-09-12 2018-09-12 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
75,000 +1.1%
1.15
US$85,912 		75,000 +1.1% 1.15 US$85,912
2018-09-12 2018-09-11 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
200,000 +2.9%
1.14
US$228,840 		200,000 +2.9% 1.14 US$228,840
2018-09-12 2018-09-11 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
200,000 +2.9%
1.14
US$228,840 		200,000 +2.9% 1.14 US$228,840
2018-09-12 2018-09-10 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
200,000 +3.0%
1.22
US$243,640 		200,000 +3.0% 1.22 US$243,640
2018-09-12 2018-09-10 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
200,000 +3.0%
1.22
US$243,640 		200,000 +3.0% 1.22 US$243,640
2018-09-07 2018-09-07 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
60,000 +0.9%
0.90
US$53,742 		60,000 +0.9% 0.90 US$53,742
2018-09-07 2018-09-07 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
60,000 +0.9%
0.90
US$53,742 		60,000 +0.9% 0.90 US$53,742
2018-09-07 2018-09-06 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
50,000 +0.8%
0.84
US$42,095 		50,000 +0.8% 0.84 US$42,095
2018-09-07 2018-09-06 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
50,000 +0.8%
0.84
US$42,095 		50,000 +0.8% 0.84 US$42,095
2018-09-07 2018-09-05 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
50,000 +0.8%
0.85
US$42,325 		50,000 +0.8% 0.85 US$42,325
2018-09-07 2018-09-05 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
50,000 +0.8%
0.85
US$42,325 		50,000 +0.8% 0.85 US$42,325
2018-08-16 2018-08-16 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
66,393 +1.0%
0.65
US$43,109 		66,393 +1.0% 0.65 US$43,109
2018-08-16 2018-08-16 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
66,393 +1.0%
0.65
US$43,109 		66,393 +1.0% 0.65 US$43,109
2018-08-16 2018-08-15 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
272,000 +4.4%
0.65
US$175,902 		272,000 +4.4% 0.65 US$175,902
2018-08-16 2018-08-15 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
272,000 +4.4%
0.65
US$175,902 		272,000 +4.4% 0.65 US$175,902
2018-08-16 2018-08-14 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
190,977 +3.2%
0.65
US$123,868 		190,977 +3.2% 0.65 US$123,868
2018-08-16 2018-08-14 B Purchase VENROCK ASSOCIATES IV L P Large shareholder
190,977 +3.2%
0.65
US$123,868 		190,977 +3.2% 0.65 US$123,868
2017-10-03 2017-09-29 B Purchase
Amin Naseem
456,432
0.00
US$0 		456,432 0.00 US$0
2017-10-03 2017-09-29 B Purchase
Peacock Jonathan M
248,962
0.00
US$0 		248,962 0.00 US$0
2017-10-03 2017-09-29 B Purchase
Luehring Jens
Large shareholder
10,000
0.00
US$0 		10,000 0.00 US$0
2016-12-12 2016-12-09 B Purchase
Luehring Jens
Non-Executive Director Large shareholder
20,000 +100.7%
0.56
US$11,200 		20,000 +100.7% 0.56 US$11,200
2016-12-01 2016-11-29 B Purchase Tenenbaum Fabian

Chief Executive Officer

Officer
142,857
0.00
US$0 		142,857 0.00 US$0
2016-12-01 2016-11-29 B Purchase Amin Naseem Non-Executive Director
714,285
0.00
US$0 		714,285 0.00 US$0
2016-11-30 2016-11-29 B Purchase Peacock Jonathan M Non-Executive Director
285,715
0.00
US$0 		285,715 0.00 US$0
2016-05-18 2016-05-17 B Purchase
Peacock Jonathan M

President and CEO

Executive Director
5,000 +2.3%
1.37
US$6,842 		5,000 +2.3% 1.37 US$6,842
2015-12-17 2015-12-16 B Purchase
Peacock Jonathan M

President and CEO

Executive Director
12,800 +32.9%
2.76
US$35,336 		12,800 +32.9% 2.76 US$35,336
2015-12-17 2015-12-15 B Purchase
Peacock Jonathan M

President and CEO

Executive Director
7,500 +23.9%
2.72
US$20,400 		7,500 +23.9% 2.72 US$20,400
2015-08-20 2015-08-19 B Purchase
Peacock Jonathan M

President and CEO

Executive Director
5,000 +18.9%
5.48
US$27,377 		5,000 +18.9% 5.48 US$27,377
2015-05-22 2015-05-20 B Purchase
Peacock Jonathan M

President and CEO

Executive Director
5,560 +26.6%
8.69
US$48,323 		5,560 +26.6% 8.69 US$48,323
2015-05-22 2015-05-20 B Purchase
MEGLASSON MARTIN

Chief Scientific Officer

Officer
712 +3.9%
8.40
US$5,981 		712 +3.9% 8.40 US$5,981
2015-02-23 2015-02-19 B Purchase
3.4
Weinstein Adam
Non-Executive Director Large shareholder
1,070,166 +28.2%
12.00
US$12,841,992 		1,070,166 +28.2% 12.00 US$12,841,992
2015-02-23 2015-02-19 B Purchase
Holt Matthew S.
Non-Executive Director Large shareholder
1,070,166 +28.2%
12.00
US$12,841,992 		1,070,166 +28.2% 12.00 US$12,841,992
2015-02-23 2015-02-19 B Purchase
1.7
NELSEN ROBERT
Non-Executive Director Large shareholder
212,666 +28.2%
12.00
US$2,551,992 		212,666 +28.2% 12.00 US$2,551,992
2015-02-23 2015-02-19 B Purchase
Luehring Jens
Non-Executive Director Large shareholder
358,916 +28.2%
12.00
US$4,306,992 		358,916 +28.2% 12.00 US$4,306,992
2015-02-23 2015-02-19 B Purchase
MEGLASSON MARTIN

Chief Scientific Officer

Officer
12,000 +187.9%
12.00
US$144,000 		12,000 +187.9% 12.00 US$144,000
2015-02-23 2015-02-19 B Purchase
Tasse Daniel
Non-Executive Director
25,000 +24.1%
12.00
US$300,000 		25,000 +24.1% 12.00 US$300,000
2015-02-23 2015-02-19 B Purchase
Naidu Manesh

Chief Business Officer

Officer
1,500 +15.3%
12.00
US$18,000 		1,500 +15.3% 12.00 US$18,000
2015-02-23 2015-02-19 B Purchase New Mountain Investments II, LLC Large shareholder
1,070,166 +28.2%
12.00
US$12,841,992 		1,070,166 +28.2% 12.00 US$12,841,992
2015-02-23 2015-02-19 B Purchase ARCH VENTURE FUND VI LP Large shareholder
212,666 +28.2%
12.00
US$2,551,992 		212,666 +28.2% 12.00 US$2,551,992
Explore more

More insider trading research around Bellerophon Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America